Abstract:Background: Cardiovascular conditions (eg, cardiac and coronary conditions, hypertensive disorders of pregnancy, and cardiomyopathies) were the leading cause of maternal mortality between 2017 and 2019. The United States has the highest maternal mortality rate of any high-income nation, disproportionately impacting those who identify as non-Hispanic Black or Hispanic. Novel clinical approaches to the detection and diagnosis of cardiovascular conditions are therefore imperative. Emerging research is demonstrating that machine learning (ML) is a promising tool for detecting patients at increased risk for hypertensive disorders during pregnancy. However, additional studies are required to determine how integrating ML and big data, such as electronic health records (EHRs), can improve the identification of obstetric patients at higher risk of cardiovascular conditions. Objective: This study aimed to evaluate the capability and timing of a proprietary ML algorithm, Healthy Outcomes for all Pregnancy Experiences-Cardiovascular-Risk Assessment Technology (HOPE-CAT), to detect maternal-related cardiovascular conditions and outcomes. Methods: Retrospective data from the EHRs of a large health care system were investigated by HOPE-CAT in a virtual server environment. Deidentification of EHR data and standardization enabled HOPE-CAT to analyze data without pre-existing biases. The ML algorithm assessed risk factors selected by clinical experts in cardio-obstetrics, and the algorithm was iteratively trained using relevant literature and current standards of risk identification. After refinement of the algorithm's learned risk factors, risk profiles were generated for every patient including a designation of standard versus high risk. The profiles were individually paired with clinical outcomes pertaining to cardiovascular pregnancy conditions and complications, wherein a delta was calculated between the date of the risk profile and the actual diagnosis or intervention in the EHR. Results: In total, 604 pregnancies resulting in birth had records or diagnoses that could be compared against the risk profile; the majority of patients identified as Black (n=482, 79.8%) and aged between 21 and 34 years (n=509, 84.4%). Preeclampsia (n=547, 90.6%) was the most common condition, followed by thromboembolism (n=16, 2.7%) and acute kidney disease or failure (n=13, 2.2%). The average delta was 56.8 (SD 69.7) days between the identification of risk factors by HOPE-CAT and the first date of diagnosis or intervention of a related condition reported in the EHR. HOPE-CAT showed the strongest performance in early risk detection of myocardial infarction at a delta of 65.7 (SD 81.4) days. Conclusions: This study provides additional evidence to support ML in obstetrical patients to enhance the early detection of cardiovascular conditions during pregnancy. ML can synthesize multiday patient presentations to enhance provider decision-making and potentially reduce maternal health disparities.

New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring

Development and validation of a machine learning algorithm for predicting the risk of postpartum depression among pregnant women

Prediction model of preeclampsia using machine learning based methods: a population based cohort study in China

Prediction of Preeclampsia Using Machine Learning and Deep Learning Models: A Review

Prediction model development of late-onset preeclampsia using machine learning-based methods

Prediction of pre-eclampsia with machine learning approaches: Leveraging important information from routinely collected data

Preeclampsia and its prediction: traditional versus contemporary predictive methods

Machine learning and disease prediction in obstetrics

Predicting intensive care need in women with preeclampsia using machine learning – a pilot study

AI-based preeclampsia detection and prediction with electrocardiogram data

A Machine Learning-Based Prediction Model for Cardiovascular Risk in Women With Preeclampsia

Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature

Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

The prediction of preeclampsia: the way forward

Prediction of Intrauterine Growth Restriction and Preeclampsia Using Machine Learning-Based Algorithms: A Prospective Study

Use of Machine Learning for Early Detection of Maternal Cardiovascular Conditions: Retrospective Study Using Electronic Health Record Data

Prediction of preeclampsia in asymptomatic women

Validation of machine-learning model for first-trimester prediction of pre-eclampsia using cohort from PREVAL study

Artificial Intelligence-Based Preeclampsia Prediction and Cost Benefits for the Health Care System in the United States

Development of non-invasive biomarkers for pre-eclampsia through data-driven cardiovascular network models

Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.